Nonetheless, the results of the present study may be applicable to patients requiring fresh embryo transfer due to limitation of time, patients with extremely high AMH levels and inadequate responses to 150–300 IU of daily rFSH, and patients with PCOS patients receiving GnRH agonist trigger [27]. This evidence concerns the gene GNRH1 and polycystic ovary syndrome.